![(3S,4S,5S,6R)-6-[[(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methoxy]-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid](https://static.cymitquimica.com/cas-image/299357-3s-4s-5s-6r-6-1s-4r-4-2-amino-6-cyclopropylamino-purin-9-yl-cyclopent-2-en-1-yl-methoxy-345-trihydroxy-tetrahydropyran-2-carboxylic-acid.png)
CAS: 384329-76-4 - (3S,4S,5S,6R)-6-[[(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methoxy]-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid
Formel:C20H26N6O7
InChl:InChI=1/C20H26N6O7/c21-20-24-16(23-9-2-3-9)11-17(25-20)26(7-22-11)10-4-1-8(5-10)6-32-19-14(29)12(27)13(28)15(33-19)18(30)31/h1,4,7-10,12-15,19,27-29H,2-3,5-6H2,(H,30,31)(H3,21,23,24,25)/t8-,10+,12+,13+,14+,15?,19-/m1/s1
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | Abacavir 5''-b-D-glucuronide REF: 7W-GC2122CAS: 384329-76-4 | ≥ 98.0% | 443,00 €~2.110,00 € | Di 16 Jul 24 |
 | Abacavir 5’-β-D-Glucuronide Sodium Salt REF: TR-A104985CAS: 384329-76-4 | - - - | 368,00 €~2.128,00 € | Mo 19 Aug 24 |
 | Abacavir 5'-β-D-glucuronide REF: 3D-MA10017CAS: 384329-76-4 | Min. 95% | Nachfragen | Di 20 Aug 24 |
Abacavir 5''-b-D-glucuronide
CAS:384329-76-4
Formel:
C20H26N6O7
Reinheit:
≥ 98.0%
Farbe und Form:
Off-white to light yellow powder
Molekulargewicht:
462.46
Ref: 7W-GC2122
| 1mg | 443,00 € | ||
| 2mg | 670,00 € | ||
| 5mg | 1.272,00 € | ||
| 10mg | 2.110,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 16. Juli 2024
Abacavir 5’-β-D-Glucuronide Sodium Salt
Kontrolliertes ProduktCAS:384329-76-4
Stability Hygroscopic Applications Abacavir 5’-β-D-Glucuronide is a metabolite of Abacavir (A105000). Abacavir is a carbocyclic …
Formel:
C20H25N6NaO7
Farbe und Form:
Neat
Molekulargewicht:
484.44
Ref: TR-A104985
| 1mg | 368,00 € | ||
| 10mg | 2.128,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Montag 19. August 2024
Abacavir 5'-β-D-glucuronide
CAS:384329-76-4
Main metabolite of antiretroviral drug Abacavir with potent activity against human immunodeficiency virus type 1 …
Formel:
C20H26N6O7
Reinheit:
Min. 95%
Farbe und Form:
Powder
Molekulargewicht:
462.46 g/mol
Ref: 3D-MA10017
| 1mg | Nachfragen | ||
| 2mg | Nachfragen | ||
| 5mg | Nachfragen | ||
| 10mg | Nachfragen | ||
| 25mg | Nachfragen |
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 20. August 2024
